Green QC but excluded reporter line
PB01-EiPS21-EGFP04 passes many QC rows but carries EGFP knock-in evidence.
Korea iPSC Source-Line Screen
Choose source lines with evidence, not optimism.
McClintock turns source-line documents, QC rows, exclusion flags, HLA readiness, and next experiments into a decision screen your CMC and wet-lab teams can actually use.
45
Evidence cells reviewed
7
Candidate lines
2
Exclusion examples
Not a LIMSNot a QMSNot diagnostic softwareSource-line decision support
Evidence Matrix
Candidate lines, blockers, HLA readiness, and next work
Category
KSCBi005-A
KSCBi018-A
KSCBi019-A
KSCBi020-A
PB01-EiPS21
Cell viability
STR authentication
Mycoplasma PCR•
HLA population fit
Commercial rights
Reporter / disease flag•
Line Decision
KSCBi005-A needs verification
HLA fitCannot compute
Next experimentHigh-res HLA
Problem
Source-line decisions are spread across evidence fragments.
Teams compare Korean bank pages, characterization reports, HLA evidence, papers, rights notes, and institutional memory before wet-lab or CMC commitments. McClintock turns that scattered record into a structured readiness matrix.
Disease-model exclusion
LQT08-hiPSC remains excluded for allogeneic source-line use despite normal characterization rows.
HLA cannot-compute state
Population fit stays null until allele-level HLA typing and reference data exist.
Next experiment queue
Evidence gaps are converted into prioritized CMC and wet-lab follow-up work.
What it answers
A Korea-first screen for evidence, blockers, HLA readiness, and next work.
- What evidence exists?
- What is missing?
- Which lines are excluded despite passing basic QC?
- Can HLA population fit be computed?
- What should be generated next?
Run a Korean iPSC source-line readiness screen.
Start with the demo catalogue, matrix, HLA page, and dossier preview.